Correction and maintenance study of subcutaneous injections of R744 to predialysis patients (phase III, comparative study in comparison with epoetin beta)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 03 Oct 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Epoetin beta; Methoxy polyethylene glycol-epoetin beta
Indications Anaemia
Focus Therapeutic Use
Sponsors Chugai Pharmaceutical

Most Recent Events

06 Jan 2009 Status changed from active, no longer recruiting to completed.
09 Jun 2008 The expected completion date for this trial is now 1 Jan 2008 as reported by ClinicalTrials.gov.
29 Jan 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight